JavaScript is required to use content on this page. Please enable JavaScript in your browser.
09/10/2025 - Self-administered FluMist
FluMist Home orders are fulfilled by AstraZeneca's partner pharmacy Asembia (ASPN) in limited quantities and select jurisdictions (which includes Maryland) during the 2025-2026 flu season. Refer to FluMist webpage for more information.
Eligible patients who self-administer the vaccine can document their administration on the Asembia/ASPN online portal. Asembia/ASPN will report these administrations to the state IIS where the vaccine was administered.
Maryland providers are not required to report these administrations, but are encouraged to check their patients' data in ImmuNet and document any gaps (if the patients were not able to report to Asembia/ASPN).
9/2/2025 - MyIR Mobile
07/13/2022 - MPX (monkeypox)
Refer to MPX information page for more details. Maryland currently follows CDC guidance to vaccinate individuals with high or intermediate risk exposure to a person with confirmed or presumed monkeypox. This may change as more vaccines become available. Thank you.